Nearly 40% of the global public feels that clinical research volunteers are ‘experimental test subjects, not people.’ While there is widespread recognition that study volunteers contribute to the advancement of public health, the research community still has plenty of opportunity to treat them as true partners in the discovery of new medical treatments. Research demonstrates that substantial progress can be made in addressing this situation with relatively minor adjustments to end-of-study practices: a commitment to sharing the findings of the trial with all volunteers who gave the gift of their participation.
This webinar will discuss the following:
- The value and feasibility of communicating clinical trial results in everyday language, from patient, sponsor and regulatory perspectives, drawing on global research conducted by the non-profit CISCRP.
- An overview of CISCRP’s program for communicating trial results to study volunteers: lessons learned and key findings from qualitative and quantitative program evaluations in our work with two dozen major and mid-size pharmaceutical and biotechnology companies since 2009.
- Recommendations and best practices to help sponsors educate and engage study volunteers in a meaningful way post-trial, while meeting growing regulatory expectations, ensuring strict non-promotionality, and minimizing burden on sponsor and site staff.
Zachary Hallinan Director of Patient Communication and Engagement Programs CISCRP
Zach Hallinan is the Director of Patient Communication and Engagement Programs at the non-profit Center for Information and Study on Clinical Research Participation (CISCRP). A graduate of the University of Pennsylvania, he oversees CISCRP’s programs for better understanding and meeting the needs of clinical research volunteers globally. He has been recognized for his work and scholarship by the American Chemical Society and the National Science Foundation, and was recognized by CenterWatch as one of 20 innovators changing the face of the clinical trials industry.
Joseph Kim, MBA Clinical Operations Director Shire
Joseph Kim serves as the Clinical Operations Director at Shire, focusing on developing and implementing innovative trial optimization solutions in an outsourced model. He has spent over 15 years in the Pharma industry utilizing a unique approach that integrates his experiences working for Sponsors, CROs, and niche vendors. He has the rare combination of experience that includes early and late phase clinical research, and a command of IT related solutions and development models. Mr. Kim was also recognized as one of “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.
Who Should Attend?
Directors, Managers, Heads of, Officers, Scientists, and Specialists in:
- Pharma and Biotech
- Contract Research Organizations
- Site Management Organizations
- Contract Manufacturing Organizations
- Research Institutions/Universities
- Institutional Review Boards/Research Ethics Boards
- Government, Regulatory Groups
- Patient Advocacy Groups
- Patient Service and Clinical Solutions Providers